Name: UMIN ID:
Unique ID issued by UMIN | UMIN000018749 |
---|---|
Receipt number | R000021233 |
Scientific Title | The effects of galantamine administration on brain network topology in patients with Alzheimer's disease (AD): A possible new biomarker for pharmacotherapy of AD |
Date of disclosure of the study information | 2015/08/21 |
Last modified on | 2020/08/24 12:45:48 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/08/21 10:31:53 | ||
2 | Update | 2016/03/25 09:06:07 | Recruitment status Anticipated trial start date |
|
3 | Update | 2016/06/22 15:48:58 | Email Name of primary person or sponsor Organization |
|
4 | Update | 2018/08/22 10:30:37 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key inclusion criteria Target sample size |
|
5 | Update | 2018/08/22 10:53:25 | Primary outcomes Primary outcomes |
|
6 | Update | 2018/08/22 10:57:49 | Last name of contact person Last name of contact person |
|
7 | Update | 2018/08/22 11:17:59 | Primary outcomes |
|
8 | Update | 2018/08/22 13:44:36 | Primary outcomes Primary outcomes |
|
9 | Update | 2019/02/25 08:46:53 | Date analysis concluded |
|
10 | Update | 2019/03/11 11:46:41 | Interventions/Control_1 Interventions/Control_1 |
|
11 | Update | 2019/03/11 12:12:09 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization1 Tel1 Organization Organization Address Address Tel |
|
12 | Update | 2019/03/11 12:21:38 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
13 | Update | 2020/02/27 10:41:40 | Recruitment status Date of IRB Last follow-up date Date analysis concluded |
|
14 | Update | 2020/02/27 10:42:32 | Number of participants that the trial has enrolled |
|
15 | Update | 2020/08/24 12:45:48 | Recruitment status Date analysis concluded |